Browse by Journal Title

2019

Sex-specific metabolic and functional differences in human umbilical vein endothelial cells from twin pairs.
Lorenz, M., Blaschke, B., Benn, A., Hammer, E., Witt, E., Kirwan, J., Fritsche-Guenther, R., Gloaguen, Y., Bartsch, C., Vietzke, A., Kramer, F., Kappert, K., Brunner, P., Nguyen, H.G., Dreger, H., Stangl, K., Knaus, P. and Stangl, V.
Atherosclerosis 291 : 99-106. December 2019

2016

Omentin-1 and risk of myocardial infarction and stroke: results from the EPIC-Potsdam cohort study.
Menzel, J., di Giuseppe, R., Biemann, R., Wittenbecher, C., Aleksandrova, K., Pischon, T., Fritsche, A., Schulze, M.B., Boeing, H., Isermann, B. and Weikert, C.
Atherosclerosis 251 : 415-421. August 2016

A lipidomic analysis approach in patients undergoing lipoprotein apheresis.
Schmoecker, C., Kassner, U., Kiesler, S., Bismarck, M., Rothe, M., Steinhagen-Thiessen, E. and Weylandt, K.H.
Atherosclerosis 249 : 30-35. June 2016

Protein sorting gone wrong - VPS10P domain receptors in cardiovascular and metabolic diseases.
Schmidt, V. and Willnow, T.E.
Atherosclerosis 245 : 194-199. February 2016

2011

Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women.
Pischon, T., Hu, F.B., Girman, C.J., Rifai, N., Manson, J.E., Rexrode, K.M. and Rimm, E.B.
Atherosclerosis 219 (1): 322-329. November 2011

2008

Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men.
Pischon, T., Hu, F.B., Rexrode, K.M., Girman, C.J., Manson, J.E. and Rimm, E.B.
Atherosclerosis 197 (1): 392-399. March 2008

2007

Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor.
Kiyan, J., Kusch, A., Tkachuk, S., Kraemer, J., Haller, H., Dietz, R., Smith, G. and Dumler, I.
Atherosclerosis 195 (2): 254-261. December 2007

2006

Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization.
Tanous, D., Braesen, J.H., Choy, K., Wu, B.J., Kathir, K., Lau, A., Celermajer, D.S. and Stocker, R.
Atherosclerosis 189 (2): 342-349. December 2006

Moderate alcohol consumption and lower levels of inflammatory markers in US men and women.
Pai, J.K., Hankinson, S.E., Thadhani, R., Rifai, N., Pischon, T. and Rimm, E.B.
Atherosclerosis 186 (1): 113-120. May 2006

2003

Apolipoprotein B-100 gene mutations and cholesterol control in German patients.
Loggen, U., Boden, A., Baron, H., Schuster, H., Tolle, R., Netwich, U., Dupon, C., Mueller-Myhsok, B. and Luft, F.C.
Atherosclerosis 166 (2): 411-412. February 2003

Patterns of oxidized epitopes, but not NF-κB expression, change during atherogenesis in WHHL rabbits.
Braesen, J.H., Haekkinen, T., Malle, E., Beisiegel, U. and Ylae-Herttuala, S.
Atherosclerosis 166 : 13-21. January 2003

2002

A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
Liu, S., Schmitz, C., Stampfer, M.J., Sacks, F., Hennekens, C.H., Lindpaintner, K. and Ridker, P.M.
Atherosclerosis 161 (2): 469-474. April 2002

Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits.
Braesen, J.H., Koenig, K., Bach, H., Kontush, A., Heinle, H., Witting, P.K., Yla-Herttuala, S., Stocker, R. and Beisiegel, U.
Atherosclerosis 163 : 249-259. 1 January 2002

High risk, high priority: familial hypercholesterolemia - a paradigm for molecular medicine.
Schuster, H.
Atherosclerosis Suppl. 2 : 27-32. 1 January 2002

2001

Tc-99m-labeled endothelin derivative for imaging of experimentally induced atherosclerosis.
Tepe, G., Duda, S.H., Meding, J., Brehme, U., Ritter, J., Hanke, H., Hilger, C.S., Claussen, C.D. and Dinkelborg, L.M.
Atherosclerosis 157 : 383-392. 1 August 2001

A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction.
Zee, R.Y., Lindpaintner, K., Struk, B., Hennekens, C.H. and Ridker, P.M.
Atherosclerosis 154 (3): 699-702. 15 February 2001

Urokinase plasminogen activator augments cell proliferation and neointima formation in injured arteries via proteolytic mechanisms.
Plekhanova, O., Parfyonova, Y., Bibilashvily, R., Domogatskii, S., Stepanova, V., Gulba, D.C., Agrotis, A., Bobik, A. and Tkachuk, V.
Atherosclerosis 159 : 297-306. 1 January 2001

1999

Concordant upregulation of type II-TGF-beta-receptor, the cyclin-dependent kinases inhibitor P27KIP1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity.
Ihling, C., Technau, K., Gross, V., Schulte-Monting, J., Zeiher, A.M. and Schaefer, H.E.
Atherosclerosis 144 : 7-14. 1 May 1999

1996

Homocysteine induced arteriosclerosis like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine.
Matthias, D., Becker, C.H., Riezler, R. and Kindling, P.H.
Atherosclerosis 122 (2): 201-216. 1 May 1996

1993

Relation of lipoprotein(a) to coronary heart disease and duplex sonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia.
Tato, F., Keller, C., Schuster, H., Spengel, F., Wolfram, G. and Zoellner, N.
Atherosclerosis 101 : 69-77. 1 January 1993